Amplify Weight Loss Drug ... (THNR)
AMEX: THNR
· Real-Time Price · USD
23.26
-0.14 (-0.61%)
At close: Sep 08, 2025, 1:16 PM
-0.61% (1D)
| Bid | 23.15 |
| Market Cap | 2.91M |
| AUM | 4.23M |
| NAV | 23.51 |
| EPS (ttm) | 1.09 |
| PE Ratio (ttm) | 21.38 |
| Shares Out | 125K |
| Inception Date | May 21, 2024 |
| Ask | 23.37 |
| Volume | 5.03K |
| Open | 23.29 |
| Previous Close | 23.40 |
| Day's Range | 23.18 - 23.29 |
| 52-Week Range | 18.56 - 27.75 |
| Holdings | 21 |
| Expense Ratio | 0.59% |
About THNR
THNR provides access to global companies expected to economically benefit from weight loss drug development. THNR seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index.
Asset Class Equity
Ticker Symbol THNR
Inception Date May 21, 2024
Provider Amplify Investments
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 64.46% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | LLY | 11.45% |
| Novo Nordisk A/s | NVO | 8.70% |
| Regeneron Pharmaceut... | REGN | 7.47% |
| Amgen Inc. | AMGN | 6.50% |
| Abbvie Inc. | ABBV | 5.64% |
| Astrazeneca PLC | AZN | 5.56% |
| Merck & Co., Inc. | MRK | 5.29% |
| Gilead Sciences, Inc... | GILD | 5.24% |
| Pfizer Inc. | PFE | 5.12% |
| Hims & Hers Health, ... | HIMS | 3.49% |
Dividends Dividend Yield 0.97%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 30, 2024 | $0.2199 | Dec 31, 2024 |
